Home » Products »

Fassisi® EhrCanis

The Fassisi® EhrCanis Test enables the reliable detection of Ehrlichia canis antibodies in whole blood, serum, or plasma within 10 minutes.


Rapid on-site diagnostics allow for immediate assessment of the infection status and early initiation of targeted treatment. This is crucial for the early detection of disease-related complications and for controlling the progression of the infection in a timely manner.

The Fassisi® EhrCanis Test offers a cost-effective and reliable solution for detecting Ehrlichia canis antibodies, allowing for the targeted evaluation of nonspecific symptoms of unknown origin. As an efficient screening tool, it is ideally suited for routine examinations and health screenings of dogs with a history of travel or from endemic areas.

EhrCanis

Ehrlichiosis

Canine monocytic ehrlichiosis (CME) is caused by the bacterium Ehrlichia canis and transmitted by the brown dog tick. Following infection, the pathogen multiplies, triggering a systemic inflammatory response. The disease can present acutely, subclinically, or chronically and is characterized by nonspecific symptoms such as fever, lethargy, anorexia, and thrombocytopenia. In chronic cases, immunosuppression, anemia, and organ involvement frequently occur, which can worsen the prognosis.

Product Information

  • Detection of E. canis (Ak)
  • Only 20 µL of serum/plasma/blood required
  • Results in 10 minutes
  • Store at 2–30°C
  • Available in kits of 5, 10, and 100
  • All materials required for testing are included in the kit

 

Performance Data

Sensitivity Specificity TTP*
EHR 92.50% 96.67% 95.00%

 

* Overall test performance, 2025 comparative test: Enzyme-Linked Immunosorbent Assay (ELISA)

Distribution